GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $21.06 and traded as low as $20.04. GENMAB A/S/S shares last traded at $20.20, with a volume of 1,747,545 shares.
GENMAB A/S/S Stock Down 0.4 %
The company’s fifty day moving average price is $21.06 and its 200 day moving average price is $22.16.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Stories
- Five stocks we like better than GENMAB A/S/S
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Best Stocks Under $5.00
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Quiet Period Expirations Explained
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
